OSC-GCDI(P)
Product Specifications
UNSPSC Description
OSC-GCDI(P) is a broad-spectrum orally active anti-influenza virus agent that exhibits significant inhibitory effects against both wild-type and Oseltamivir (HY-13317) resistant (H275Y) influenza virus strains in mouse infection models. OSC-GCDI(P) is capable of preventing not only wild-type influenza viruses but also OS-resistant variants with NA(H275Y)[1].
Target Antigen
Influenza Virus
Type
Reference compound
Related Pathways
Anti-infection
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/osc-gcdi-p.html
Smiles
O=C(N1/C(C2C(C3=CC=CC=C3C2=O)=O)=N\[C@H]4CC(C(O)=O)=C[C@@H](OC(CC)CC)[C@@H]4NC(C)=O)C5=CC=CC=C5C1=O
Molecular Weight
585.60
References & Citations
[1]Jung Y, et al. A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents[J]. ACS Central Science, 2024.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162680/OSC-GCDI-P-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162680/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RPU56273-01 50 µg
Recombinant Rho Associated Coiled Coil Containing Protein Kinase 2 (Rock2)
Ask
View Details RPU56273-02 100 µg
Recombinant Rho Associated Coiled Coil Containing Protein Kinase 2 (Rock2)
Ask
View Details